In the news
Prime Therapeutics buying Magellan Health’s pharma business for $1.35 billion
May 5, 2022Minneapolis/St. Paul Business Journal
Related news
In the news
March 13, 2024
Prime Therapeutics and Capital Rx Create Technology Alliance
Formulary Watch